Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
PSTV
Plus Therapeutics
Last Price:
1.15
Seasonality Move:
2.43%
7 Day Trial
ALL ACCESS PASS
$
7
Start Collecting Your $4,243 Monthly Paycheck Next Week
CLICK HERE to get started.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Sell |
20-day SMA: | 1.28 | Sell |
50-day SMA: | 1.32 | Sell |
200-day SMA: | 1.65 | Sell |
8-day EMA: | 1.28 | Sell |
20-day EMA: | 1.29 | Sell |
50-day EMA: | 1.33 | Sell |
200-day EMA: | 1.67 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 38.61 | Sell |
Chaikin Money Flow: | -26085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.34) | Sell |
Bollinger Bands (100): | (1.25 - 1.57) | Sell |
Plus Therapeutics Technical Analysis
Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.17 while PSTV 8-day simple moving average is 1.31, which is a Sell signal.
- The stock price of PSTV is 1.17 while Plus Therapeutics 20-day SMA is 1.28, which makes it a Sell.
- Plus Therapeutics 50-day simple moving average is 1.32 while PSTV share price is 1.17, making it a Sell technically.
- PSTV stock price is 1.17 and Plus Therapeutics 200-day simple moving average is 1.65, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
41
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.17. The Score for PSTV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
6.9M
Price in USD:
1.17
Share Volume:
69.56K
Plus Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
1.12
Sell
41
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.17 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.17 while PSTV 8-day exponential moving average is 1.28, which is a Sell signal.
- The stock price of PSTV is 1.17 while Plus Therapeutics 20-day EMA is 1.29, which makes it a Sell.
- Plus Therapeutics 50-day exponential moving average is 1.33 while PSTV share price is 1.17, making it a Sell technically.
- PSTV stock price is 1.17 and Plus Therapeutics 200-day simple moving average is 1.67, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Plus Therapeutics is a Sell
- Plus Therapeutics Relative Strength Index (RSI) is 38.61, which suggest Plus Therapeutics is oversold
- The Bollinger Bands (25) for Plus Therapeutics is (1.2 - 1.34), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (1.25 - 1.57), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.